Product Introduction:
Pulmocef CV 250/125 mg Tablet is a combination of Cefuroxime Axetil (250 mg), a second-generation cephalosporin antibiotic, and Clavulanic Acid (125 mg), a beta-lactamase inhibitor. This combination provides broad-spectrum antibacterial activity, including protection against beta-lactamase–producing resistant bacteria.
Uses:
-
Respiratory tract infections (bronchitis, pneumonia)
-
Ear, nose, and throat infections
-
Urinary tract infections
-
Skin and soft tissue infections
-
Sinusitis and tonsillitis
Benefits:
-
Effective against resistant bacterial strains
-
Broad-spectrum coverage
-
Quick symptomatic relief from bacterial infections
-
Convenient oral dosage
Composition:
-
Cefuroxime Axetil – 250 mg
-
Clavulanic Acid – 125 mg
Side Effects:
-
Diarrhea
-
Nausea or vomiting
-
Abdominal discomfort
-
Skin rash
-
Rare: Allergic reactions, liver enzyme elevations
Safety Advice:
-
Take after meals to improve absorption and reduce stomach upset
-
Complete the full prescribed course even if symptoms improve
-
Do not skip doses to avoid antibiotic resistance
-
Consult doctor if symptoms persist or worsen
-
Store in a dry place below 25°C
-
Keep out of reach of children
